Cargando…

Vinorelbine Augments Radiotherapy in Hepatocellular Carcinoma

There is a need to improve the effectiveness of radiotherapy (RT) in hepatocellular carcinoma (HCC). Therefore, the purpose of this study was to explore the efficacy and toxicity of the anti-microtubule agent Vinorelbine as a radiosensitizer in HCC. The radio sensitivity of 16 HCC patient-derived xe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeoh, Kheng Wei, Prawira, Aldo, Saad, Muhammad Zafrie Bin, Lee, Kok Ming, Lee, Eric Ming Hon, Low, Gee Keng, Mohd Nasir, Mohamed Hakim Bin, Phua, Jun Hao, Chow, Wendy Wan Li, Lim, Iris Jiu Hia, Omar, Yusnita Binte, Ho, Rebecca Zhi Wen, Le, Thi Bich Uyen, Vu, Thanh Chung, Soo, Khee Chee, Huynh, Hung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226273/ https://www.ncbi.nlm.nih.gov/pubmed/32260169 http://dx.doi.org/10.3390/cancers12040872

Ejemplares similares

FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2020)

Ribociclib enhances infigratinib‐induced cancer cell differentiation and delays resistance in FGFR‐driven hepatocellular carcinoma
por: Prawira, Aldo, et al.
Publicado: (2020)

Upregulation of the ErbB family by EZH2 in hepatocellular carcinoma confers resistance to FGFR inhibitor
por: Prawira, Aldo, et al.
Publicado: (2021)

Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma
por: Le, Thi Bich Uyen, et al.
Publicado: (2020)

Vinorelbine – a clinical review
por: Gregory, R K, et al.
Publicado: (2000)

Learning from Covid 19 in a level 1 oral and maxillofacial trauma centre – Insights for the future
por: Yeoh, Melvyn, et al.
Publicado: (2023)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer
por: Huang, Liang, et al.
Publicado: (2019)

Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)
por: Sim, Sung Hoon, et al.
Publicado: (2019)

Vinorelbine induced perforation of a metastatic gastric lesion
por: Mullally, W. J., et al.
Publicado: (2016)

Carboplatin/vinorelbine: Worsening of lung adenocarcinoma: case report
Publicado: (2022)

Apatinib plus vinorelbine versus vinorelbine for metastatic triple-negative breast cancer who failed first/second-line treatment: the NAN trial
por: Li, Dou-Dou, et al.
Publicado: (2022)

Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study
por: Liu, Chien-Ting, et al.
Publicado: (2021)

Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study
por: Li, Yi, et al.
Publicado: (2021)

Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane
por: Ahn, Jin-Hee, et al.
Publicado: (2004)

Methods of preventing vinorelbine-induced phlebitis: an experimental study in rabbits
por: Kohno, Emiko, et al.
Publicado: (2008)

Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
por: Devleena,, et al.
Publicado: (2010)

Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis
por: Pétain, Aurélie, et al.
Publicado: (2019)

Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy
por: Wang, Yue-shen, et al.
Publicado: (2016)

Ten future challenges for synthetic biology
por: Gallup, Olivia, et al.
Publicado: (2021)

Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study Group
por: Fløtten, Ø, et al.
Publicado: (2012)

Combined use of apatinib mesylate and vinorelbine versus vinorelbine alone in recurrent or metastatic triple-negative breast cancer: study protocol for a randomized controlled clinical trial
por: Wu, Shuo, et al.
Publicado: (2020)

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, in vitro
por: Simoens, Cindy, et al.
Publicado: (2008)

Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer
por: Faller, Bryan A., et al.
Publicado: (2011)

A Timely Oral Option: Single‐Agent Vinorelbine in Desmoid Tumors
por: Gennatas, Spyridon, et al.
Publicado: (2020)

LINC-26. ORAL VINORELBINE IN PROGRESSIVE UNRESECTABLE LOW-GRADE GLIOMA
por: Cappellano, Andréa M, et al.
Publicado: (2020)

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer
por: McLaughlin, Shannon, et al.
Publicado: (2023)

N-acetylcysteine attenuates the incidence of phlebitis induced by carbomer/vinorelbine gel
por: Zhang, Hongyu, et al.
Publicado: (2023)

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer
por: Yeon, Sang Hoon, et al.
Publicado: (2023)

A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study
por: Vici, Patrizia, et al.
Publicado: (2011)

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
por: Lerouge, Delphine, et al.
Publicado: (2014)

Ictal Electroencephalogram Visual Pattern Recognition of Seizure Adequacy During Electroconvulsive Therapy Treatment: A Step-by-Step Approach
por: Yee, Kenny Ong Kheng, et al.
Publicado: (2023)

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
por: Sørensen, J B, et al.
Publicado: (2008)

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines
por: Berruti, A, et al.
Publicado: (2005)

A phase II, multicentre, UK study of vinorelbine in advanced breast cancer.
por: Twelves, C. J., et al.
Publicado: (1994)

VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma
por: Sinha, Sutapa, et al.
Publicado: (2010)

Successful Concurrent Chemoradiotherapy with Cisplatin plus Vinorelbine for Locally Advanced Thymic Carcinoma
por: Fukushima, Toshirou, et al.
Publicado: (2014)

Vinorelbine-induced regression of a choroidal metastasis from primary breast carcinoma
por: Arya, Malvika, et al.
Publicado: (2018)

Is there still a place for vinorelbine in advanced metastatic castration resistant prostate cancer?
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study
por: Morimoto, Yoshihito, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gead4pu4tj8gr9mth4eek1s65p